ENCORE MEDICAL, LP
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$144.3M
Doctors Paid
2,960
Transactions
41,396
2024 Total
$19.9M
Payment Breakdown by Category
Royalty/License$100.9M (69.9%)
Consulting$30.4M (21.1%)
Travel$3.5M (2.4%)
Research$1.6M (1.1%)
Food & Beverage$1.1M (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $100.9M | 2,038 | 69.9% |
| Consulting Fee | $30.4M | 10,440 | 21.1% |
| Acquisitions | $5.2M | 20 | 3.6% |
| Travel and Lodging | $3.5M | 11,263 | 2.4% |
| Unspecified | $1.6M | 368 | 1.1% |
| Honoraria | $1.2M | 481 | 0.8% |
| Food and Beverage | $1.1M | 16,579 | 0.7% |
| Space rental or facility fees (teaching hospital only) | $171,911 | 30 | 0.1% |
| Grant | $167,250 | 28 | 0.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $44,786 | 43 | 0.0% |
| Debt forgiveness | $34,105 | 19 | 0.0% |
| Gift | $17,500 | 55 | 0.0% |
| Education | $4,564 | 32 | 0.0% |
Payments by Type
General
$142.7M
41,028 transactions
Research
$1.6M
368 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| PS-706 - e-plus | $168,854 | 5 | 87 |
| Siverhus DJO-16-101 | $123,657 | 0 | 19 |
| Entezari DJO-20-006A | $93,902 | 0 | 5 |
| Prospective multicenter study to examine the influence of repairing the sub-scapularis on outcomes after reverse arthroplasty: A randomized, controlled trial | $85,766 | 1 | 24 |
| Early Feasibility Study of the Percutaneous Osseointegrated Prosthesis POP device. | $84,338 | 0 | 2 |
| DJO Hip Replacement System Outcomes | $50,596 | 0 | 4 |
| Furman PS-806 SAR | $46,500 | 1 | 24 |
| Clinical Outcomes of DJO Altivate Reverse Total Shoulder ArthroplastyRSA | $46,250 | 0 | 4 |
| Influence of the Outpatient Arthroplasty Risk Assessment Tool During Pre-operative Education on Patient Decision for Early Discharge Following Shoulder Arthroplasty | $42,500 | 0 | 5 |
| Jawa DJO-17-102 | $39,500 | 0 | 4 |
| Early Feasibility Study of the Percutaneous Osseointegrated Prosthesis (POP) device. | $38,561 | 0 | 2 |
| The Effect of Stem Length on Reverse Total Shoulder Humeral Fixation | $36,400 | 0 | 5 |
| Predictors of Patient Outcome After Revision to Reverse Shoulder Arthroplasty of a Failed Hemiarthroplasty | $35,907 | 0 | 1 |
| Frankle DJO-17-111 | $33,814 | 1 | 2 |
| FRANKLE-DJO-21SUR-011-FORE | $32,400 | 0 | 4 |
| Frankle DJO-18-012 | $29,900 | 0 | 3 |
| FRANKLE-DJO-20-009A | $29,439 | 0 | 1 |
| Prospective multicenter study to examine the influence of repairing the sub-scapularis on outcomes after reverse arthroplasty A randomized, controlled trial | $28,833 | 1 | 16 |
| Evaluation of Proximal Humeral Bone Loss in Revision Surgery for Failed Hemiarthroplasty | $28,800 | 0 | 1 |
| Frankle DJO-17-110 | $28,614 | 1 | 2 |
| FRANKLE-DJO-21SUR-009-FORE | $28,490 | 0 | 4 |
| FRANKLE-DJO-21SUR-006-FORE | $28,223 | 0 | 4 |
| FRANKLE-DJO-20-007A | $26,268 | 0 | 3 |
| FRANKLE-DJO-21SUR-007-FORE | $25,822 | 0 | 4 |
| Trends in revision shoulder arthroplasty: Changes in indications, reasons for revision, and treatment options | $25,789 | 0 | 2 |
| Clinical Outcomes of DJO Altivate Reverse Total Shoulder Arthroplasty(RSA) | $25,000 | 0 | 1 |
| FRANKLE-DJO-21INT-003A | $24,153 | 0 | 3 |
| Viroslav PS-807 SAN | $23,495 | 0 | 4 |
| A Prospective multicenter study to examine the influence of repairing the sub-scapularis on outcomes after reverse arthroplasty: A randomized, controlled trial. | $22,779 | 1 | 9 |
| FRANKLE-DJO-21SUR-008-FORE | $22,358 | 0 | 4 |
Payments by Medical Specialty
Top Paid Doctors — Page 3
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Adam Freedhand, M.d, M.D | Orthopaedic Surgery | Houston, TX | $408,242 | $0 |
| Stanton Longenecker, Md, MD | Orthopaedic Surgery | Jacksonville, FL | $407,154 | $0 |
| Dr. Kenneth Sands, Md, MD | Orthopaedic Surgery | Melbourne, FL | $401,053 | $0 |
| Charles Toulson, Md, MD | Orthopaedic Surgery | Mckinney, TX | $355,580 | $0 |
| Norman Kane, M.d, M.D | Orthopaedic Surgery | Carlsbad, CA | $342,366 | $0 |
| Robert Easton, Md, MD | Orthopaedic Surgery | Baton Rouge, LA | $330,759 | $0 |
| Andrew Green, M.d, M.D | Sports Medicine | Providence, RI | $327,525 | $0 |
| James Germano, M.d, M.D | Orthopaedic Surgery | Rockville Centre, NY | $326,223 | $0 |
| Dr. Peter Hanson, Md, MD | Orthopaedic Surgery | La Mesa, CA | $323,839 | $0 |
| Dr. Richard Reitman, M.d, M.D | Adult Reconstructive Orthopaedic Surgery | Plano, TX | $315,932 | $0 |
| Dr. Douglas Padgett, Md, MD | Specialist | New York, NY | $304,820 | $0 |
| Randall Otto, M.d, M.D | Orthopaedic Surgery | Fenton, MO | $294,808 | $0 |
| David Dodgin, M.d, M.D | Orthopaedic Surgery | Austin, TX | $286,524 | $0 |
| Dr. Shahan Yacoubian, Md, MD | Adult Reconstructive Orthopaedic Surgery | Burbank, CA | $278,596 | $0 |
| Bassem Elhassan, M.d, M.D | Hand Surgery | Rochester, MN | $277,666 | $0 |
| Dr. Jason Hsu, Md, MD | Orthopaedic Surgery | Seattle, WA | $275,982 | $0 |
| Dr. Stephan Pill, Md, MD | Sports Medicine | Greenville, SC | $272,190 | $0 |
| Dr. Carl Talmo, Md, MD | Orthopaedic Surgery | Boston, MA | $265,243 | $0 |
| Brian Palumbo, Md, MD | Adult Reconstructive Orthopaedic Surgery | Temple Terrace, FL | $259,767 | $0 |
| Dr. Michael Kang, M.d, M.D | Orthopaedic Surgery | New York, NY | $255,257 | $0 |
| Dr. Adam Seidl, M.d, M.D | Student in an Organized Health Care Education/Training Program | Aurora, CO | $241,417 | $0 |
| Matthew Walker, Md, MD | Orthopaedic Surgery | Richmond, VA | $230,708 | $0 |
| Dr. Samuel Taylor, M.d, M.D | Orthopaedic Surgery | New York, NY | $225,706 | $0 |
| Dr. Sridhar Durbhakula, M.d, M.D | Orthopaedic Surgery | Bethesda, MD | $221,106 | $0 |
| Dr. Michael Ries, Md, MD | Adult Reconstructive Orthopaedic Surgery | Reno, NV | $215,269 | $0 |
Ad
Top Products
- DJO SURGICAL $56.5M
- DJO Surgical AltiVate Reverse $26.7M
Associated Products (24)
- DJO SURGICAL $56.5M
- DJO Surgical AltiVate Reverse $26.7M
- DJO Surgical Empowr Knee System $11.7M
- DJO Surgical AltiVate Anatomic System $7.2M
- DJO Surgical Turon Modular Shoulder System $6.6M
- DJO Surgical TaperFill Hip System $3.8M
- DJO Surgical Exprt Revision Knee $3.5M
- DJO Surgical Exprt Revision Hip $1.6M
- DJO Surgical 3DKnee System $1.5M
- DJO Surgical Discovery Elbow System $1.3M
- DJO Surgical Empowr Acetabular System $814,456
- DJO Surgical Match Point System $652,767
- DJO Surgical Foundation Knee $621,145
- DJO Surgical FMP Acetabular System $423,655
- DJO Surgical Empowr Acetabular Cup $359,550
- DJO Surgical CLP Hip System $326,625
- DJO Surgical Revelation Hip System $219,561
- DJO Surgical Linear Hip System $207,477
- DJO Surgical STAR Ankle $103,364
- DJO Surgical Cobalt HV Bone Cement $100,458
- DJO Surgical Alians Proximal Humerus Fracture Plate $88,679
- DJO Surgical EPIK Uni Knee $70,453
- DJO Surgical Foundation Hip System $34,822
- DJO Surgical Motivation and S.U.R.E. System $21,313
Payment Categories
- Food & Beverage $1.1M
- Consulting $30.4M
- Travel & Lodging $3.5M
- Research $1.6M
- Royalties $100.9M
About ENCORE MEDICAL, LP
ENCORE MEDICAL, LP has made $144.3M in payments to 2,960 healthcare providers, recorded across 41,396 transactions in the CMS Open Payments database. In 2024, the company paid $19.9M. The top product by payment volume is DJO SURGICAL ($56.5M).
Payments were distributed across 68 medical specialties. The top specialty by payment amount is Orthopaedic Surgery ($109.6M to 1,858 doctors).
Payment categories include: Food & Beverage ($1.1M), Consulting ($30.4M), Research ($1.6M), Travel & Lodging ($3.5M), Royalties ($100.9M).
ENCORE MEDICAL, LP is associated with 24 products in the CMS Open Payments database, including DJO SURGICAL, DJO Surgical AltiVate Reverse, and DJO Surgical Empowr Knee System.